Department of Clinical Science, Intervention and Technology, Division of Transplantation Surgery, Karolinska Institutet, Huddinge, Sweden.
Perioperative Medicine and Intensive Care, Karolinska University Hospital, Huddinge, Sweden.
Acta Anaesthesiol Scand. 2020 Jul;64(6):742-750. doi: 10.1111/aas.13556. Epub 2020 Feb 20.
Acute kidney injury (AKI) is frequently observed after orthotopic liver transplantation (OLT) even in patients with previously normal renal function. In this study, we investigated the impact of factors such graft steatosis, post-reperfusion syndrome (PRS), and hepatic ischemia reperfusion injury (HIRI) on the development of AKI after OLT in adult patients.
We retrospectively examined consecutive adult patients who underwent OLT at our institution between July 2011 and June 2017. AKI was diagnosed based on the criteria proposed by the International Kidney Disease Improving Global Outcomes (KDIGO) workgroup. Peak aspartate aminotransferase (AST) level within 72 hours after OLT was used as a surrogate marker for HIRI. Graft steatosis was diagnosed by histopathological examination using specimens biopsied intraoperatively at the end of transplantation procedure and categorized as <10%, 10%-20%, 20%-30%, and ≥30% of hepatic steatosis.
Out of 386 patients, 141 (37%) developed AKI (KDIGO stage 1:71 patients; stage 2:29 patients; stage 3:41 patients). Multivariable logistic regression analysis revealed that cold ischemic time (P = .012) and HIRI (P = .007) were independent risk factors for post-OLT AKI. Multivariable analysis also revealed that graft steatosis was associated with HIRI but not directly with AKI. PRS was not associated with HIRI or AKI in the multivariable analyses.
Our results indicate that greater severity of liver graft injury during transplantation negatively affects renal function after OLT. As expected, the severity of liver graft steatosis contributes to accelerated liver injury occurring during the transplantation procedure.
即使在肾功能正常的患者中,原位肝移植(OLT)后也经常会发生急性肾损伤(AKI)。在本研究中,我们研究了供体脂肪变性、再灌注后综合征(PRS)和肝缺血再灌注损伤(HIRI)等因素对成人OLT 后 AKI 发展的影响。
我们回顾性检查了 2011 年 7 月至 2017 年 6 月在我院接受 OLT 的连续成年患者。根据国际肾脏病改善全球结局(KDIGO)工作组提出的标准诊断 AKI。OLT 后 72 小时内的天冬氨酸转氨酶(AST)峰值用作 HIRI 的替代标志物。通过在移植过程结束时对术中活检标本进行组织病理学检查诊断供体脂肪变性,并将其分为<10%、10%-20%、20%-30%和≥30%的肝脂肪变性。
在 386 例患者中,有 141 例(37%)发生 AKI(KDIGO 分期 1:71 例;分期 2:29 例;分期 3:41 例)。多变量逻辑回归分析显示冷缺血时间(P=0.012)和 HIRI(P=0.007)是 OLT 后 AKI 的独立危险因素。多变量分析还显示,供体脂肪变性与 HIRI 相关,但与 AKI 无关。PRS 在多变量分析中与 HIRI 或 AKI 无关。
我们的结果表明,移植过程中肝移植物损伤的严重程度恶化会对 OLT 后肾功能产生负面影响。正如预期的那样,肝移植物脂肪变性的严重程度导致移植过程中发生加速的肝损伤。